Why IQuant?

As a scientist who has been discovering and developing CNS drugs for the past 25 years, I’ve worked on a wide variety of diverse projects. Although each project involved unique mechanisms and novel indications, they shared a common requirement: a foundational understanding of the scientific literature, patents, funding landscape, and clinical trial activity. As if this wasn’t daunting enough, it is equally critical for scientists to understand and engage with the network of experts within each topic area. Who is doing the best work? Who could be a strong collaborator? Who shows leadership and innovation? 

Even though answering these questions accurately is a time-consuming and resource intensive process, it is fundamentally necessary for progress in any project. This is a monumental task, as even within the narrowest of research areas the vast number of papers and pace of change is nearly overwhelming. Staying current is often severely compromised by the sad fact that much of the scientific literature is either unreliable, irrelevant, or downright fraudulent. After decades in the field, I knew there must be a more effective and efficient way to integrate useful knowledge without devoting limited free time to poring through endless documents, most of questionable relevance.

In contrast to my initial academic career, where the topic area was well-defined and stable over time, the shift to drug discovery and development required a more applied research sensibility together with greater intellectual agility. Shifting project priorities, new disease areas, and unplanned opportunities all required the tools to pivot rapidly and quickly gain the necessary scientific background.  Each change called for detailed intelligence gleaned from voluminous, but often flawed publications. I found myself seeking new, more efficient ways to embrace each such challenge. Basic searches on Pubmed or Medline proved counterproductive, largely due to the sheer weight of information to digest. The more advanced databases such as those offered by big publishers (you probably have sales e-mails from them sitting in your spam folders right now) demanded expensive subscriptions and yet were only marginally better. Contracting with vendors to create white papers or topic dossiers was equally frustrating, each at a price point approaching six figures(!) and requiring at least six months and too much of my time. After being thoroughly disappointed by the lack of acceptable options, my partner Benjamin and I began a collaboration to address this need.

Intuitive Quantitation’s founding principles and capabilities arose directly from these experiences. With a fundamental belief in unlocking the incredible value buried in publicly available data, we worked together to create the Iquant Engine. Iquant was built to rapidly find the best collaborators for preclinical work or Key Opinion Leaders for clinical programs. We provide the most critical background information to support due diligence, identify strengths, catch flaws, and uncover hidden opportunities. Iquant does this through comprehensive searches of public data, unique analytics that integrate metadata, decisive interpretation, and fully documented methods. Our products provide quick, detailed results that never require subscriptions – the insights, analysis, and data provided belong to you.

As a company we will continue to conduct research and develop related technologies for integrating data, communicating results, and facilitating progress through knowledge. We are committed to sharing our results on a regular basis, either here or in peer-reviewed, open-source journals. Check back regularly for new posts discussing the capabilities and uses of the Iquant Engine. Please use our contact form if you have any questions or are interested in working together on your next project.

Let us know how we can help enhance your research.

We work with scientists, drug discovery professionals, pharmaceutical companies and researchers to create custom reports and precision analytics to fit your project's needs – with more transparency, on tighter timelines, and prices that make sense.

Why IQuant?

As a scientist who has been discovering and developing CNS drugs for the past 25 years, I’ve worked on a wide variety of diverse projects. Although each project involved unique mechanisms and novel indications, they shared a common requirement: a foundational understanding of the scientific literature, patents, funding landscape, and clinical trial activity. As if this wasn’t daunting enough, it is equally critical for scientists to understand and engage with the network of experts within each topic area. Who is doing the best work? Who could be a strong collaborator? Who shows leadership and innovation? Even though answering these questions accurately is a time-consuming and resource intensive process, it is fundamentally necessary for progress in any project. 

This is a monumental task, as even within the narrowest of research areas the vast number of papers and pace of change is nearly overwhelming. Staying current is often severely compromised by the sad fact that much of the scientific literature is either unreliable, irrelevant, or downright fraudulent. After decades in the field, I knew there must be a more effective and efficient way to integrate useful knowledge without devoting limited free time to poring through endless documents, most of questionable relevance.

In contrast to my initial academic career, where the topic area was well-defined and stable over time, the shift to drug discovery and development required a more applied research sensibility together with greater intellectual agility. Shifting project priorities, new disease areas, and unplanned opportunities all required the tools to pivot rapidly and quickly gain the necessary scientific background.  Each change called for detailed intelligence gleaned from voluminous, but often flawed publications. I found myself seeking new, more efficient ways to embrace each such challenge. 

Basic searches on Pubmed or Medline proved counterproductive, largely due to the sheer weight of information to digest. The more advanced databases such as those offered by big publishers (you probably have sales e-mails from them sitting in your spam folders right now) demanded expensive subscriptions and yet were only marginally better. Contracting with vendors to create white papers or topic dossiers was equally frustrating, each at a price point approaching six figures(!) and requiring at least six months and too much of my time. After being thoroughly disappointed by the lack of acceptable options, my partner Benjamin and I began a collaboration to address this need.

Intuitive Quantitation’s founding principles and capabilities arose directly from these experiences. With a fundamental belief in unlocking the incredible value buried in publicly available data, we worked together to create the Iquant Engine. Iquant was built to rapidly find the best collaborators for preclinical work or Key Opinion Leaders for clinical programs. We provide the most critical background information to support due diligence, identify strengths, catch flaws, and uncover hidden opportunities. Iquant does this through comprehensive searches of public data, unique analytics that integrate metadata, decisive interpretation, and fully documented methods. Our products provide quick, detailed results that never require subscriptions – the insights, analysis, and data provided belong to you.

As a company we will continue to conduct research and develop related technologies for integrating data, communicating results, and facilitating progress through knowledge. We are committed to sharing our results on a regular basis, either here or in peer-reviewed, open-source journals. Check back regularly for new posts discussing the capabilities and uses of the Iquant Engine. Please use our contact form if you have any questions or are interested in working together on your next project.

Let us know how we can help enhance your research.

We work with scientists, drug discovery professionals, pharmaceutical companies and researchers to create custom reports and precision analytics to fit your project's needs – with more transparency, on tighter timelines, and prices that make sense.